User login

Inside U.S. Trade - 12/06/2019

GOP lawmakers lament proposed scale-back of biologics protections in USMCA

December 4, 2019 at 6:00 PM
Republican lawmakers on Wednesday expressed concern about reports the Trump administration is willing to give up language on protections for biologic drugs in the U.S.-Mexico-Canada Agreement, but one ardent supporter of strong data exclusivity provisions in trade deals suggested the move would not affect his support for USMCA. Rep. George Holding (R-NC), a member of the House Ways & Means trade subcommittee, told Inside U.S. Trade the reports were disappointing. He called strong biologics protections in trade deals critical...


Not a subscriber? You can request 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.